Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

January 10, 2013 | Customer News

Cavro® Air Displacement Pipettor provides the key to automated sonochemical synthesis

The robotic arm manipulates the Cavro ADP within the purge box

Männedorf, Switzerland, January 10, 2013 – Go2 Technologies, a specialized engineering solutions provider in Dayton, Ohio, has used Tecan’s Cavro Air Displacement Pipettor (ADP) to develop a novel automated method for labor­intensive sonochemical synthesis of nanoparticles for the generation of hydrogen gas. Kent Walker, Partner/Owner at Go2 Technologies, explained: “This is a very labor-intensive procedure for a single operator, and we were approached to develop an automated method that could robotically dispense, mix, sonicate and verify, essentially to produce a robotic synthesis machine to automate the manual pipetting and dispensing stages within a nitrogen-purged environment.”


“The really big challenge of the whole process was liquid dispensing; we needed something compact and lightweight that could cover a large range of volumes, from 15 µl to 10 ml. The nature of the liquids used meant that we needed to find a non-contact mechanism for dispensing and pumping, with tips that were either disposable, or that could be removed and replaced during the process. This was where the Cavro ADP really came into play. Each of the liquids that we pipette has its own rack of tips and, once they have been used, we just dispense them into a waste container. Consistency is essential for the synthesis to work, and the Cavro ADP has been vital to the success of the project.”


To find out more on Tecan’s Cavro ADP, visit www.tecan.com/components 



For more information please contact

Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf

Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12



About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).